Credit Agricole’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254M Sell
275,920
-35,455
-11% -$35.9M 0.67% 22
2025
Q4
$335M Buy
311,375
+7,943
+3% +$7.59M 0.76% 19
2025
Q3
$232M Buy
+303,432
New +$226M 0.61% 26
2025
Q1
$292M Buy
353,041
+23,024
+7% +$19.2M 0.92% 16
2024
Q4
$255M Buy
330,017
+140,185
+74% +$116M 0.75% 23
2024
Q3
$168M Buy
189,832
+11,227
+6% +$10.1M 0.72% 31
2024
Q2
$162M Buy
178,605
+117,465
+192% +$94M 0.87% 21
2024
Q1
$45.6M Buy
61,140
+23,401
+62% +$16.7M 0.49% 36
2023
Q4
$22M Buy
37,739
+14,623
+63% +$8.54M 0.25% 73
2023
Q3
$12.4M Buy
23,116
+6,260
+37% +$3.23M 0.2% 97
2023
Q2
$7.91M Buy
16,856
+1,156
+7% +$485K 0.14% 127
2023
Q1
$5.39M Sell
15,700
-9,128
-37% -$3.08M 0.11% 149
2022
Q4
$9.08M Sell
24,828
-7,943
-24% -$2.82M 0.19% 101
2022
Q3
$10.6M Sell
32,771
-10,502
-24% -$3.33M 0.2% 78
2022
Q2
$14M Sell
43,273
-13,679
-24% -$4.11M 0.34% 62
2022
Q1
$16.3M Sell
56,952
-1,981
-3% -$510K 0.29% 63
2021
Q4
$16.3M Sell
58,933
-2,566
-4% -$650K 0.26% 64
2021
Q3
$14.2M Buy
61,499
+3,131
+5% +$773K 0.27% 66
2021
Q2
$13.4M Sell
58,368
-5,827
-9% -$1.17M 0.27% 64
2021
Q1
$12M Buy
64,195
+15,265
+31% +$2.99M 0.31% 63
2020
Q4
$8.26M Sell
48,930
-10,630
-18% -$1.59M 0.27% 78
2020
Q3
$8.82M Buy
59,560
+26,398
+80% +$4.09M 0.47% 57
2020
Q2
$5.44M Buy
33,162
+32,632
+6,157% +$5.01M 0.35% 78
2020
Q1
$74K Hold
530
0.01% 297
2019
Q4
$70K Buy
530
+100
+23% +$11.6K ﹤0.01% 295
2019
Q3
$48K Hold
430
﹤0.01% 380
2019
Q2
$48K Buy
430
+100
+30% +$11.8K ﹤0.01% 375
2019
Q1
$43K Buy
330
+100
+43% +$12.2K ﹤0.01% 386
2018
Q4
$27K Hold
230
﹤0.01% 415
2018
Q3
$25K Buy
+230
New +$23K ﹤0.01% 395
2017
Q4
Sell
-1,162,559
Closed -$99.4M 765
2017
Q3
$99.4M Sell
1,162,559
-5,496
-0.5% -$451K 0.34% 73
2017
Q2
$96.1M Buy
1,168,055
+143,362
+14% +$11.7M 0.32% 76
2017
Q1
$86.2M Sell
1,024,693
-375,273
-27% -$30.1M 0.26% 85
2016
Q4
$103M Buy
1,399,966
+109,121
+8% +$8.13M 0.33% 68
2016
Q3
$104M Buy
1,290,845
+652,456
+102% +$52.2M 0.34% 61
2016
Q2
$50.3M Buy
638,389
+150,069
+31% +$11.3M 0.19% 124
2016
Q1
$35.2M Sell
488,320
-324,132
-40% -$24.5M 0.17% 159
2015
Q4
$68.5M Buy
812,452
+461,415
+131% +$38.3M 0.32% 69
2015
Q3
$29.4M Buy
351,037
+32,964
+10% +$2.78M 0.15% 152
2015
Q2
$26.6M Sell
318,073
-27,010
-8% -$2.06M 0.12% 189
2015
Q1
$25.1M Sell
345,083
-33,798
-9% -$2.41M 0.11% 200
2014
Q4
$26.2M Buy
378,881
+28,092
+8% +$1.9M 0.11% 211
2014
Q3
$22.7M Sell
350,789
-37,447
-10% -$2.37M 0.1% 238
2014
Q2
$24.1M Sell
388,236
-104,016
-21% -$6.21M 0.1% 238
2014
Q1
$29M Sell
492,252
-418
-0.1% -$23.3K 0.12% 223
2013
Q4
$25.1M Sell
492,670
-39,467
-7% -$1.98M 0.1% 246
2013
Q3
$26.8M Buy
+532,137
New +$27.9M 0.12% 224

Other funds holding LLY

Credit Agricole's LLY Position: Q1 2026 in Review

Credit Agricole reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $35.9M and leaving 275,920 shares worth $254M. The position accounts for 0.67% of the portfolio, ranked #22.

Credit Agricole first reported a position in LLY in Q3 2013 and has held it in 47 quarters since. The position peaked at $335M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Credit Agricole held 275,920 shares of Eli Lilly worth $254M as of Q1 2026.
  • Credit Agricole sold 35,455 Eli Lilly shares in Q1 2026, an estimated $35.9M.
  • Eli Lilly made up 0.67% of Credit Agricole's portfolio in Q1 2026, its #22 holding.
  • Credit Agricole first reported a position in Eli Lilly in Q3 2013 and has held it in 47 quarters since.
  • Credit Agricole's Eli Lilly position peaked at $335M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.